Evidence map›Paper›PMID 38804025›Full record

ReviewYonsei medical journal2024

Exercise Across the Phases of Cancer Survivorship: A Narrative Review.

Ki-Yong An, Jihee Min, Dong Hoon Lee, Dong-Woo Kang, Kerry S Courneya, Justin Y Jeon

Abstract readReview
In one paragraph

Review in Yonsei medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ki-Yong AnFaculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0001-7529-1314
Jihee MinNational Cancer Control Institute, National Cancer Center, Goyang, Korea.ORCID https://orcid.org/0000-0003-0858-2124
Dong Hoon LeeDepartment of Sport Industry Studies, Yonsei University, Seoul, Korea.ORCID https://orcid.org/0000-0003-1329-4637
Dong-Woo KangDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID https://orcid.org/0000-0003-2292-1946
Kerry S CourneyaFaculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-9677-3918
Justin Y JeonDepartment of Sport Industry Studies, Yonsei University, Seoul, Korea.ORCID https://orcid.org/0000-0001-7978-4271

Funding

Yonsei Signature Research Cluster Project 2021-22-0009Yonsei University 2023-22-0159
6 · The paper itself

Abstract

Exercise has long been recognized as an important component of treatment for various diseases. However, the benefits and risks of exercise interventions must be carefully evaluated to ensure the former outweighs the latter. As cancer patients undergo diverse treatment modalities with distinct objectives, a systematic approach partitioning the cancer journey into distinct phases is necessary to inform tailored exercise prescriptions. This narrative review summarizes exercise benefits and mechanisms for cancer patients and survivors across four distinct survivorship periods-before surgery, after surgery and before adjuvant treatment, during nonsurgical treatment (adjuvant and neoadjuvant), and during extended survival. In summary, exercise reduces the risks of complications and declines in physical functioning while improving fatigue, quality of life, and the ability to manage treatment effects. Although additional research is warranted, existing evidence is sufficient to integrate exercise into clinical oncology practice and cancer survivorship programs.

Indexed as

Cancer SurvivorsExerciseNeoplasmsQuality of LifeExercise TherapyFatigueHumansSurvivorshipadjuvant chemotherapycancer survivorsExerciseneoplasms

Identifiers

PMID38804025
PMCPMC11130592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.